IOBTQ · IO Biotech, Inc. · Executive Compensation
$0.00
+0.00 (+0.00%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“Our recurring losses from operations raise substantial doubt about our ability to continue as a going concern. As a result, the financial statements accompanying this Quarterly Report on Form 10-Q include a statement that there is substantial doubt about our ability to continue as a going concern for one year after the date the financial statements were issued, and these financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.”View the 10-Q filed Nov 14, 2025
Market Cap
$7,194
Shares
71.95M
Volume · Oct 2
600
Avg daily vol (3M)
110K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Mai-Britt Zocca | Ph.D., Chief Executive Officer and Founder | $1,839,811 |
| Qasim Ahmad | M.D., Chief Medical Officer | $1,057,504 |
| Amy Sullivan | M.B.A., Chief Financial Officer | $998,412 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mai-Britt Zocca | Ph.D., Chief Executive Officer and Founder | $1,645,088 |
| Eva Ehrnrooth | M.D., Ph.D., Former Chief MedicalOfficer )^ | $967,722 |
| Qasim Ahmad | M.D., Chief Medical Officer | $920,756 |
| Devin W. Smith | — | $917,300 |
| Amy Sullivan | M.B.A., Chief Financial Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Mai-Britt Zocca | Ph.D., Chief Executive Officer and Founder | $733,875 |
| Amy Sullivan | Chief Financial Officer | $635,173 |
| Eva Ehrnrooth | M.D., Ph.D., Former Chief MedicalOfficer )^ | $565,840 |
| General Counsel | — | — |
| Qasim Ahmad | M.D., Chief Medical Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mai-Britt Zocca | Ph.D., Chief Executive Officer and Founder | $8,153,333 |
| Eva Ehrnrooth | M.D., Ph.D., Chief Medical Officer | $2,704,051 |
| Muhammad Al-Hajj | Chief Scientific Officer | $2,678,227 |
| Amy Sullivan | Chief Financial Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Eva Ehrnrooth | M.D., Ph.D., Chief Medical Officer | $450,127 |
| Mai-Britt Zocca | Ph.D., Chief Executive Officer and Founder | $409,349 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Amy Sullivan | Chief Financial Officer and Chief Accounting Officer | Terminated | 2026-03-31 |
| Amy Sullivan | Chief Financial Officer and Chief Accounting Officer | Terminated | 2026-03-31 |
| Mai-Britt Zocca | Chief Executive Officer | Terminated | 2026-03-31 |
| David Smith | Board of Directors | Resigned | 2026-03-31 |
| Heidi Hunter | Board of Directors | Resigned | 2026-03-31 |
| Kathleen Glaub | Board of Directors | Resigned | 2026-03-31 |
| Christian Elling | Board of Directors | Resigned | 2026-03-31 |
| Helen Collins | Board of Directors | Resigned | 2026-03-31 |
| Peter Hirth | Board of Directors | Resigned | 2026-03-31 |
| Qasim Ahmad, M.D. | Chief Medical Officer | Terminated | 2026-01-30 |
| Brian Burkavage | Senior Vice President and Chief Accounting Officer | Resigned | 2025-11-21 |
| Jack Nielsen | member of the board of directors | Resigned | 2024-04-26 |
| Helen Collins, M.D. | Class II director | Appointed | 2023-11-13 |
| Priyanka Belawat | member of the Board of Directors | Resigned | 2023-08-11 |
| Heidi Hunter | Class II director | Appointed | 2023-08-11 |
| Qasim Ahmad, M.D. | Chief Medical Officer | Appointed | 2023-07-18 |
| Vanessa Malier | member of the board of directors | Resigned | 2023-04-20 |
| Amy Sullivan | Chief Financial Officer | Appointed | 2022-10-13 |